Friedman, M. A., Le, B., Stevens, J., Desmarais, J., Seifer, D., Ogle, K., . . . Rosenbaum, J. T. (2021). Tofacitinib as a steroid-sparing therapy in pulmonary sarcoidosis, an open-label prospective proof-of-concept study. Lung.
Stile di citazione ChicagoFriedman, Marcia A., et al. "Tofacitinib As a Steroid-sparing Therapy in Pulmonary Sarcoidosis, an Open-label Prospective Proof-of-concept Study." Lung 2021.
Citazione MLAFriedman, Marcia A., et al. "Tofacitinib As a Steroid-sparing Therapy in Pulmonary Sarcoidosis, an Open-label Prospective Proof-of-concept Study." Lung 2021.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.